The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monday Deal Review: August 3, 2009

B&W_BigNickelHopefully, the Deal Review will be a longer list as the newly-launched Ontario Emerging Technologies Fund starts deploying some capital, but for this week, the Canadian deal front was pretty quiet.   A few developments, like the JLL-Patheon pathos and the milestone for Cardiome from Merck, were noted at the time in our Twitter stream @crossborderbio, and aside from that there are only a few deals, and a bit of bad news, to check out 

Deals:

There were also a number of Canadian companies pulling back this week, including:

Share Button

About these ads

3 responses to “Monday Deal Review: August 3, 2009

  1. Pingback: Monday Deal Review: August 28, 2009 « The Cross-Border Biotech Blog

  2. Pingback: Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog

  3. Pingback: Monday Biotech Deal Review: November 23, 2009 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers